注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Candel Therapeutics Inc是一家處於臨床階段的生物製藥公司。該公司專註於用溶瘤病毒免疫療法幫助患者抗擊癌癥。其設計的病毒通過病毒介導的細胞毒性在癌細胞中誘發免疫性死亡,因此釋放出腫瘤新抗原,並在註射部位創造出有利炎癥的微環境。該公司有兩個臨床階段的病毒免疫治療平臺,分別基於新型的、經過基因改造的腺病毒和單純皰疹病毒(HSV)構建體。其兩個候選產品包括CAN-2409和CAN-3110。CAN-2409是一種基於腺病毒的、復製缺陷的工程基因構建體,編碼來自單純皰疹病毒的胸苷激酶基因。其enLIGHTEN發現平臺是基於HSV的系統性、叠代性發現平臺,利用人類生物學和先進的分析技術,創造出治療實體瘤的新病毒免疫療法。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Paul B. Manning | 66 | 2018 | Independent Chairman |
Paul-Peter Tak | 61 | 2020 | President, CEO & Director |
Estuardo Aguilar-Cordova | 63 | 2002 | Founder & Director |
Henry Brem | 69 | 2021 | Member of Research Advisory Board |
Scott Eggener | - | - | Member of Scientific Advisory Board |
Steven M. Albelda | - | - | Member of Scientific Advisory Board |
Daniel H. Sterman | - | - | Member of Scientific Advisory Board |
Padmanee Sharma | - | 2021 | Member of Research Advisory Board |
Philip W. Kantoff | 67 | 2021 | Member of Research Advisory Board |
Patrick Yung Wen | - | - | Member of Scientific Advisory Board |
E. Antonio Chiocca | - | - | Member of Scientific Advisory Board |
James Patrick Allison | - | 2021 | Member of Research Advisory Board |
Charu Aggarwal | - | - | Member of Scientific Advisory Board |
Tri Le | - | - | Member of Scientific Advisory Board |
Mark Bloomston | - | - | Member of Scientific Advisory Board |
Diem Nguyen | 50 | 2021 | Independent Director |
Adam Kibel | - | - | Member of Scientific Advisory Board |
Christopher Martell | 43 | 2018 | Independent Director |
Edward J. Benz | 76 | 2017 | Member of Research Advisory Board & Director |
Renee M. Gaeta | 41 | 2022 | Independent Director |
Joseph C. Papa | 66 | 2022 | Independent Director |
Nicoletta Loggia | - | 2023 | Independent Director |
Gary J. Nabel | 69 | 2022 | Member of Research Advisory Board & Director |
Roy Steven Herbst | 61 | 2021 | Member of Research Advisory Board |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核